Quick Takeaways
- INGALLS & SNYDER LLC filed SCHEDULE 13G/A for CORCEPT THERAPEUTICS INC COMMON STOCK (CORT).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2025.
INGALLS & SNYDER LLC - 31 Dec 2025 SCHEDULE 13G/A Report for CORCEPT THERAPEUTICS INC COMMON STOCK (CORT)
- Filing Manager
- INGALLS & SNYDER LLC
- Reporting Manager
- INGALLS & SNYDER LLC
- Symbol
- CORT
- Shares outstanding
- 106,815,676 shares
- Disclosed Ownership
- 7,263,466 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 21 Apr 2026, 16:20:37 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 21 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INGALLS & SNYDER LLC disclosed 6.8% ownership in CORCEPT THERAPEUTICS INC COMMON STOCK (CORT) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 21 Feb 2025.
- Current filing was accepted on 21 Apr 2026, 16:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 6.8% | 7,263,466 | 0 | 0 | THOMAS O BOUCHER JR | MANGER |